Variable | Without ISMN (n = 62) | With ISMN (n = 46) | P value |
---|---|---|---|
Baseline Demographics | |||
Age, years | 64.3 ± 10.1 | 65.0 ± 11.1 | 0.75 |
Male, n (%) | 42(67.7) | 31(86.1) | 1.0 |
Body mass index, kg/m2 | 26.3 ± 3.9 | 25.0 ± 3.6 | 0.09 |
Hypertension, n (%) | 15(24.2) | 5(10.9) | 0.09 |
Smoking, n (%) | 29(46.8) | 23(50.0) | 0.70 |
Insulin therapy, n (%) | 13(21.0) | 7(15.2) | 0.62 |
Creatinine, mmol/L | 141.1 ± 137.4 | 128.8 ± 91.9 | 0.59 |
HbA1c, % | 7.8 ± 2.6 | 7.8 ± 1.4 | 0.92 |
Total cholesterol, mmol/L | 4.4 ± 1.0 | 4.5 ± 1.3 | 0.88 |
Triglyceride, mmol/L | 1.9 ± 1.6 | 2.1 ± 4.0 | 0.76 |
HDL cholesterol, mmol/L | 1.1 ± 0.2 | 1.2 ± 0.2 | 0.18 |
LDL cholesterol, mmol/L | 2.6 ± 0.9 | 2.5 ± .7 | 0.76 |
Triple vessel disease, n (%) | 3(4.8) | 11(23.9) | *0.01 |
Prior myocardial infarction, n (%) | 15(24.2) | 18(39.1) | 0.14 |
Prior PCI, n (%) | 17(27.4) | 18(39.1) | 0.21 |
Drug eluting stent, n (%) | 43(69.4) | 31(67.4) | 0.84 |
Impaired LVEF < 50%, n(%) | 13(21.0) | 7(15.2) | 0.62 |
Medications after PCI | |||
Beta blocker, n (%) | 50(80.6) | 38(82.6) | 1.0 |
Calcium channel blocker, n (%) | 43(69.4) | 29(63.0) | 0.40 |
Statin, n (%) | 54(87.1) | 41(89.1) | 1.0 |
ACEI/ARB, n (%) | 53(85.5) | 39(84.8) | 0.77 |
Aldosterone blocker, n (%) | 6(9.7) | 1(2.2) | 0.14 |